Russia covid vaccine: Early trials of 2nd vaccine finished, no side-effects seen
Vector virology institute today completed Phase II trials of a second potential Russian vaccine against COVID-19, Interfax news agency reported. In August, Russia had registered its first vaccine candidate, developed…